Trials / Sponsors / Jacqueline Garcia, MD
Jacqueline Garcia, MD
Academic / Other · 5 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | Assessing PI3K Gamma Inhibition With Azacitidine, Venetoclax and Eganelisib in Patients With Acute Myeloid Leu Leukemia, Myeloid, Leukemia, Acute Myeloid Leukemia | Phase 1 | 2026-07-01 |
| Recruiting | A Multi-Site Break Through Cancer Trial: Targeting Measurable Residual Disease in Patients With Acute Myeloid Acute Myeloid Leukaemia (AML), Leukemia, Blood Cancer | Phase 1 / Phase 2 | 2026-02-02 |
| Active Not Recruiting | Combination Navitoclax, Venetoclax and Decitabine for Advanced Myeloid Neoplasms Myeloid Malignancy, Myelodysplastic Syndromes, Myelofibrosis | Phase 1 | 2022-07-18 |
| Active Not Recruiting | Venetoclax Added to Fludarabine + Busulfan Prior to Transplant and to Maintenance Therapy for AML, MDS, and MD Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Chronic Myelomonocytic Leukemia (CMML) | Phase 1 | 2018-10-24 |
| Completed | Combination Merestinib and LY2874455 for Patients With Relapsed or Refractory Acute Myeloid Leukemia Relapsed Adult Acute Myeloid Leukemia, Refractory Adult Acute Myeloid Leukemia | Phase 1 | 2017-08-10 |